Bell en Gong Archief | euronext.com

Zoeken Contact

Deze pagina is beschikbaar is meerdere talen

Select Language

Envipco admitted to trading

18/02/2021 - 8:46AM CET | Oslo

1721204d4fad112-7a88-4567-a529-4920670fd8e5
Envipco admitted to trading
Envipco admitted to trading on Euronext Growth Oslo 18 February 2021.
Envipco admitted to trading

18/02/2021 - 8:46AM CET Oslo
Sonans admitted to trading

17/02/2021 - 8:50AM CET | Oslo

172119452a4c293-e1c4-42f2-a50b-992d93cf0a27
Sonans admitted to trading
Sonans admitted to trading on Euronext Growth Oslo 17 February 2021.
Sonans admitted to trading

17/02/2021 - 8:50AM CET Oslo
Technip Energies lists on Euronext Paris

16/02/2021 - 9:33AM CET | Paris

Technip Energies lists on Euronext Paris

Arnaud Pieton , Chief Executive Officer of Technip Energies , opens the trading day in Paris.

Created from the spin-off from TechnipFMC plc group in 2021, Technip Energies N.V. is an Engineering and Technology company specialized in providing projects, technologies, products and services on energy infrastructure both onshore and offshore (LNG, downstream, sustainable chemistry, hydrogen, CO2 management and marine infrastructure).

1721189b326e721-3f3d-4d89-b2ed-d3a2c84051d5
Technip Energies lists on Euronext Paris
Arnaud Pieton , Chief Executive Officer of Technip Energies , opens the trading day in Paris.

Created from the spin-off from TechnipFMC plc group in 2021, Technip Energies N.V. is an Engineering and Technology company specialized in providing projects, technologies, products and services on energy infrastructure both onshore and offshore (LNG, downstream, sustainable chemistry, hydrogen, CO2 management and marine infrastructure).
Technip Energies lists on Euronext Paris

16/02/2021 - 9:33AM CET Paris
Pryme admitted to trading

16/02/2021 - 8:50AM CET | Oslo

17211860a36f2b0-4612-416a-a15e-7ec1d66e3c54
Pryme admitted to trading
Pryme admitted to trading on Euronext Growth Oslo 16 February 2021.
Pryme admitted to trading

16/02/2021 - 8:50AM CET Oslo
Huddly admitted to trading

16/02/2021 - 8:44AM CET | Oslo

17211859da27dd2-8a26-41ab-ad31-31beb57ffa44
Huddly admitted to trading
Huddly admitted to trading on Euronext Growth Oslo 16 February 2021.
Huddly admitted to trading

16/02/2021 - 8:44AM CET Oslo
Rize ETF – ETFs Listings

15/02/2021 - 9:52AM CET | Amsterdam

Rize ETF – ETFs Listings

Rize ETF viert dat zij vandaag drie ETF’s noteren op Euronext. Jason Kennard, mede-oprichter van Rize ETF, luidde daarom op afstand de gong. Dit deed hij in het bijzijn van onder meer Thomas Weber, ETFs Manager Bedrijfsontwikkeling bij Euronext. De 3 genoteerde ETFs zijn Cybersecurity, Edtech en Sustainable food.

17211846a60565d-72b6-4a27-b1a0-e3c7786e2aeb
Rize ETF – ETFs Listings
Rize ETF viert dat zij vandaag drie ETF’s noteren op Euronext. Jason Kennard, mede-oprichter van Rize ETF, luidde daarom op afstand de gong. Dit deed hij in het bijzijn van onder meer Thomas Weber, ETFs Manager Bedrijfsontwikkeling bij Euronext. De 3 genoteerde ETFs zijn Cybersecurity, Edtech en Sustainable food.
Rize ETF – ETFs Listings

15/02/2021 - 9:52AM CET Amsterdam
ESG Core Investments – SPAC Listing en eerste handelsdag

12/02/2021 - 10:27AM CET | Amsterdam

ESG Core Investments – SPAC Listing en eerste handelsdag

Hans Slootweg, Managing Director van ESG Core Investments, werd verwelkomd door Simone Huis in ’t Veld, CEO van Euronext Amsterdam. Van Roij luidde de gong naar aanleiding van de notering van ESG Core Investments, een Special Purpose Acquistion Company (SPAC) met een sterke focus op Environment, Social and Governance (ESG). Het is de eerste SPAC-listing op Euronext van dit jaar.

172117958e26566-938f-4fe0-b01a-4dcb55e2135a
ESG Core Investments – SPAC Listing en eerste handelsdag
Hans Slootweg, Managing Director van ESG Core Investments, werd verwelkomd door Simone Huis in ’t Veld, CEO van Euronext Amsterdam. Van Roij luidde de gong naar aanleiding van de notering van ESG Core Investments, een Special Purpose Acquistion Company (SPAC) met een sterke focus op Environment, Social and Governance (ESG). Het is de eerste SPAC-listing op Euronext van dit jaar.
ESG Core Investments – SPAC Listing en eerste handelsdag

12/02/2021 - 10:27AM CET Amsterdam
Beaconsmind lists on Euronext Access+ Paris

12/02/2021 - 9:43AM CET | Paris

Beaconsmind lists on Euronext Access+ Paris

Max Weiland , CEO and Founder, of Beaconsmind , open the trading day in Paris.

Beaconsmind AG specializes in the development of location-based marketing software solutions for retailers. The group allows retailers to carry out marketing campaigns to increase customer loyalty, revenue and sales at the point of sale and in online.

17211767f0031f7-1e9c-461e-9d4c-faf7dc8f7cf3
Beaconsmind lists on Euronext Access+ Paris
Max Weiland , CEO and Founder, of Beaconsmind , open the trading day in Paris.

Beaconsmind AG specializes in the development of location-based marketing software solutions for retailers. The group allows retailers to carry out marketing campaigns to increase customer loyalty, revenue and sales at the point of sale and in online.
Beaconsmind lists on Euronext Access+ Paris

12/02/2021 - 9:43AM CET Paris
Medesis Pharma lists on Euronext Growth Paris

12/02/2021 - 9:38AM CET | Paris

Medesis Pharma lists on Euronext Growth Paris

Jean-Claude Maurel , CEO and Founder of Medesis Pharma, opens the trading day in Paris.

Medesis Pharma S.A. is specialized in the research and development, based on a breakthrough technology (AONYS®) for the delivery of therapeutic molecules, of drugs to treat diseases for which there is no effective treatment.

The company's portfolio includes two candidates in the fields of neurodegenerative diseases (Alzheimer's disease and Huntington's disease), two candidates for antiviral treatments to respond to the health emergency towards the treatment of COVID-19 at different stages (one for hospitalized patients in acute respiratory distress, and another for early treatment in urban medicine), and 2 candidates to treat contaminated populations after a civil or military nuclear accident (Plutonium decorporation and cesium decorporation).

17211757c955456-40eb-4b72-b703-6cf3dea0ff06
Medesis Pharma lists on Euronext Growth Paris
Jean-Claude Maurel , CEO and Founder of Medesis Pharma, opens the trading day in Paris.

Medesis Pharma S.A. is specialized in the research and development, based on a breakthrough technology (AONYS®) for the delivery of therapeutic molecules, of drugs to treat diseases for which there is no effective treatment.

The company's portfolio includes two candidates in the fields of neurodegenerative diseases (Alzheimer's disease and Huntington's disease), two candidates for antiviral treatments to respond to the health emergency towards the treatment of COVID-19 at different stages (one for hospitalized patients in acute respiratory distress, and another for early treatment in urban medicine), and 2 candidates to treat contaminated populations after a civil or military nuclear accident (Plutonium decorporation and cesium decorporation).
Medesis Pharma lists on Euronext Growth Paris

12/02/2021 - 9:38AM CET Paris
UBS Asset Management

10/02/2021 - 10:03AM CET | Amsterdam

UBS Asset Management – 20 jaar ETFs

UBS Asset Management vierde vandaag dat zij al twintig jaar ETFs aanbieden. Marcel Danen, Executive Director van UBS, luidde daarom op afstand de gong, in het bijzijn van onder meer Brieuc Louchard, verantwoordelijk voor ETFs binnen Euronext. Tien jaar geleden lanceerde het bedrijf haar eerste duurzame ETF en sinds vijf jaar zijn verschillende ETFs genoteerd aan de Amsterdamse beurs.

1721171e01215ac-2613-45ac-9343-4eba8092f65a
UBS Asset Management – 20 jaar ETFs
UBS Asset Management vierde vandaag dat zij al twintig jaar ETFs aanbieden. Marcel Danen, Executive Director van UBS, luidde daarom op afstand de gong, in het bijzijn van onder meer Brieuc Louchard, verantwoordelijk voor ETFs binnen Euronext. Tien jaar geleden lanceerde het bedrijf haar eerste duurzame ETF en sinds vijf jaar zijn verschillende ETFs genoteerd aan de Amsterdamse beurs.
UBS Asset Management

10/02/2021 - 10:03AM CET Amsterdam
Hydrogen Refueling Solutions

09/02/2021 - 11:46AM CET | Paris

Hydrogen Refueling Solutions lists on Euronext Growth Paris

Hassen Rachedi , CEO and Founder, Philippe Bottu, General Manager, and Olivier Dhez, Business Development & Marketing Director of Hydrogen Refueling Solutions , open the trading day in Paris.

Hydrogen Refueling Solutions is specialized in the mass production of turnkey hydrogen refueling stations with large capacities (100 kg to 1 ton) for heavy vehicles (transport, buses, garbage trucks, etc.) and passenger vehicles.

At the end of 2020, the group has a production site located in France.

1721168e6f2aa11-7c06-43e0-8e73-bfcfe11319ac
Hydrogen Refueling Solutions lists on Euronext Growth Paris
Hassen Rachedi , CEO and Founder, Philippe Bottu, General Manager, and Olivier Dhez, Business Development & Marketing Director of Hydrogen Refueling Solutions , open the trading day in Paris.

Hydrogen Refueling Solutions is specialized in the mass production of turnkey hydrogen refueling stations with large capacities (100 kg to 1 ton) for heavy vehicles (transport, buses, garbage trucks, etc.) and passenger vehicles.

At the end of 2020, the group has a production site located in France.
Hydrogen Refueling Solutions

09/02/2021 - 11:46AM CET Paris
Cambi admitted to trading

09/02/2021 - 8:43AM CET | Oslo

1721166c236457f-5af3-4b48-8ac2-6cb07813c16a
Cambi admitted to trading
Cambi admitted to trading on Euronext Growth Oslo 9 February 2021.
Cambi admitted to trading

09/02/2021 - 8:43AM CET Oslo
Pherecydes Pharma lists on Euronext Growth Paris

05/02/2021 - 9:11AM CET | Paris

Pherecydes Pharma lists on Euronext Growth Paris

Guy-Charles Fanneau de La Horie, CEO of Pherecydes Pharma, opens the trading day in Paris.

Pherecydes Pharma is specialized in the research and development of anti-infective therapies based on bacteriophages. Phagotherapy is an innovative approach to treat bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.

172115949f396c4-4243-44b5-a6bb-c3217c8b6b65
Pherecydes Pharma lists on Euronext Growth Paris
Guy-Charles Fanneau de La Horie, CEO of Pherecydes Pharma, opens the trading day in Paris.

Pherecydes Pharma is specialized in the research and development of anti-infective therapies based on bacteriophages. Phagotherapy is an innovative approach to treat bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.
Pherecydes Pharma lists on Euronext Growth Paris

05/02/2021 - 9:11AM CET Paris
Okeanis Eco Tankers listed on Oslo Børs

04/02/2021 - 11:07AM CET | Oslo

1721152b708caf2-302b-4481-a125-3dd43b7d1e21
Okeanis Eco Tankers listed on Oslo Børs
Okeanis Eco Tankers listed on Oslo Børs 29 January 2021.
Okeanis Eco Tankers listed on Oslo Børs

04/02/2021 - 11:07AM CET Oslo
Kick-off TechShare Nederland 2020-2021

04/02/2021 - 9:58AM CET | Amsterdam

Kick-off TechShare Nederland 2020-2021

Alexander Voorham, accountmanager Listings van Euronext Amsterdam, luidde de gong als aftrap van het TechShare Nederland 2020-2021 programma. TechShare is het opleidingsprogramma van Euronext voor Tech entrepreneurs. Het laat hen kennismaken met de mogelijkheden van de financiële kapitaalmarkten.

172115110b52b77-c3f0-4e13-8c9a-38cf4ae6020a
Kick-off TechShare Nederland 2020-2021
Alexander Voorham, accountmanager Listings van Euronext Amsterdam, luidde de gong als aftrap van het TechShare Nederland 2020-2021 programma. TechShare is het opleidingsprogramma van Euronext voor Tech entrepreneurs. Het laat hen kennismaken met de mogelijkheden van de financiële kapitaalmarkten.
Kick-off TechShare Nederland 2020-2021

04/02/2021 - 9:58AM CET Amsterdam
Wereldkankerdag

03/02/2021 - 9:49AM CET | Amsterdam

Wereldkankerdag

Op Wereldkankerdag wordt er meer dan anders gevraagd om aandacht te geven aan kankerpatiënten. Samen met Dick Plomp, ervaringsdeskundige namens de Nederlandse Federatie van Kankerpatiëntenorganisaties, luidde Euronext’s communicatiemanager Marianne Aalders vanochtend de gong.

1721147518c8f9f-aa17-4935-be99-9950e47e51cb
Wereldkankerdag
Op Wereldkankerdag wordt er meer dan anders gevraagd om aandacht te geven aan kankerpatiënten. Samen met Dick Plomp, ervaringsdeskundige namens de Nederlandse Federatie van Kankerpatiëntenorganisaties, luidde Euronext’s communicatiemanager Marianne Aalders vanochtend de gong.
Wereldkankerdag

03/02/2021 - 9:49AM CET Amsterdam
Proximar Seafood admitted to trading

03/02/2021 - 8:43AM CET | Oslo

17211453c1c0ce2-2d94-4545-b533-045a21c59503
Proximar Seafood admitted to trading
Proximar Seafood admitted to trading on Euronext Growth Oslo 3 February 2021.
Proximar Seafood admitted to trading

03/02/2021 - 8:43AM CET Oslo
Winnaar KVK Innovatie Top 100

01/02/2021 - 10:29AM CET | Amsterdam

Winnaar KVK Innovatie Top 100

Het bedrijf Somnox, bekend van hun slaaprobot, is de winnaar van de 15^e editie van de Kamer van Koophandel’s Innovatie Top 100. Alexander Voorham, accountmanager Listings van Euronext Amsterdam, luidde vandaag ter gelegenheid hiervan de gong namens Somnox’ CEO Julian Jagtenberg.

172113710dcd786-3063-49b2-882f-01b63364a8e3
Winnaar KVK Innovatie Top 100
Het bedrijf Somnox, bekend van hun slaaprobot, is de winnaar van de 15^e editie van de Kamer van Koophandel’s Innovatie Top 100. Alexander Voorham, accountmanager Listings van Euronext Amsterdam, luidde vandaag ter gelegenheid hiervan de gong namens Somnox’ CEO Julian Jagtenberg.
Winnaar KVK Innovatie Top 100

01/02/2021 - 10:29AM CET Amsterdam